The dopamine D1 receptor agonist SKF-82958 serves as a discriminative stimulus in the rat

European Journal of Pharmacology

Volumn 388, Issue 2, 2000, Pages 125-131

  Haile, Colin N ^a   Carey, Galen ^a   Varty, Geoffrey B ^a   Coffin, Vicki L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cocaine; Dopamine; Dopamine D1 receptor agonist; Drug discrimination; Rat; SCH 39166; SKF 82958

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; QUINPIROLE; RACLOPRIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG DISCRIMINATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BENZAZEPINES; COCAINE; CUES; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1;

EID: 0033959592     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00864-X     Document Type: Article

References (43)

1. 1 receptor efficacy. Eur. J. Pharmacol. 188:1990;335-347.
2. 2 agonist (-)-NPA are mediated by separate mechanisms. Life Sci. 42:1988;565-574.
3. Baker L.E., Riddle E.E., Saunders R.B., Appel J.B. The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behav. Pharmacol. 4:1993;69-79.
4. Barrett R.L., Appel J.B. Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine. Psychopharmacology. 99:1989;13-16.
5. Broadbent J., Michael E.K., Riddle E.E., Appel J.B. Involvement of dopamine uptake in the discriminative stimulus properties of cocaine. Behav. Pharmacol. 2:1991;187-197.
6. 2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J. Pharmacol. Exp. Ther. 270:1994;209-218.
7. 2 mediation of the discriminative stimulus properties of D-amphetamine and cocaine. Psychopharmacology. 103:1991;50-55.
8. 2 receptor function in rats. J. Pharmacol. Exp. Ther. 266:1993;585-592.
9. 1 receptors in the nucleus accumbens. Psychopharmacology. 115:1994;110-114.
10. Callahan P.M., De La Garza R. II, Cunningham K.A. Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems. Pharmacol. Biochem. Behav. 57:1997;601-607.
11. 1 receptor mediation of the discriminative stimulus properties of SKF-38393. Eur. J. Pharmacol. 119:1985;121-125.
12. Filip M., Przegalinski E. The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats. Polish J. Pharmacol. 49:1997;21-30.
13. 2 receptors in mediating the D-amphetamine discriminative cue. Eur. J. Pharmacol. 202:1991;191-199.
14. 1 receptor agonists by squirrel monkeys. Psychopharmacology. 125:1996;97-104.
15. 1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat. Eur. J. Pharmacol. 246:1993;39-44.
16. 2 dopamine agonists in rats. J. Pharmacol. Exp. Ther. 242:1987;804-811.
17. 1 dopamine agonist SKF-38393 functions as a discriminative stimulus in rats. Psychopharmacology. 87:1985;368-370.
18. Kantak K.M., Edwards M.A., Spealman R.D. Effects of N-methyl-D-aspartate antagonists in rats discriminating different doses of cocaine: comparison with direct and indirect dopamine agonists. J. Pharmacol. Exp. Ther. 274:1995;657-665.
19. 1 dopamine receptor agonists, SKF-38393, on behavior maintained by cocaine injection in squirrel monkeys. Psychopharmacology. 109:1992;241-244.
20. Kleven M.S., Anthony E.W., Woolverton W.L. Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J. Pharmacol. Exp. Ther. 254:1990;312-317.
21. Koob G.F., Nestler E.J. The neurobiology of drug addiction. J. Neuropsychiatry Clin. Neurosci. 9:1997;482-497.
22. Kosten T.A., Haile C.N., Jatlow P. Naltrexone and morphine alter the discrimination and plasma levels of ethanol. Behav. Pharmacol. 10:1999;1-13.
23. Mendelson J.H., Mello N.K. Drug therapy: management of cocaine abuse and dependence. New Engl. J. Med. 334:1996;965-972.
24. 1 dopamine receptor. Neuropharmacology. 28:1989;401-405.
25. 1 agonist, SKF-81297. Behav. Pharmacol. 4:1993;135-146.
26. Roberts D.C., Corcoran M.E., Fibiger H.C. On the role of ascending catacholaminergic systems in intravenous self-administration of cocaine. Pharmacol. Biochem. Behav. 6:1977;615-620.
27. Roberts D.C., Koob G.F. Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area. Pharmacol. Biochem. Behav. 17:1982;901-904.
28. 1 receptor involvement in the discriminative stimulus effects of SKF-81297 in squirrel monkeys. J. Pharmacol. Exp. Ther. 267:1993;765-775.
29. 1 dopamine agonist dihydrexidine in the rat. Psychopharmacology. 119:1995;79-84.
30. 2-like dopamine receptor agonists. Science. 271:1996;1586-1589.
31. 2, receptors. Psychopharmacology. 123:1996;303-306.
32. 1 agonists SKF-82958 and SKF-77434 are self-administered by rats. Brain Res. 582:1992;349-352.
33. 2 dopamine receptors in the behavioral effects of cocaine. Neurochem. Int. 20:1992;1475-1525.
34. Spealman R.D., Bergman J., Madras B.K., Melia K.F. Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. J. Pharmacol. Exp. Ther. 258:1991;945-953.
35. 1 agonists. Psychopharmacology. 133:1997;283-292.
36. 2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature. 294:1981;366-368.
37. Varty G.B., Higgins G.A. Investigation into the nature of a 7-OH-DPAT discriminative cue: comparison with D-amphetamine. Eur. J. Pharmacol. 339:1997;101-107.
38. 1 agonists in monkeys. J. Pharmacol. Exp. Ther. 283:1997;29-38.
39. 1 receptor agonists in rhesus monkeys. J. Pharmacol. Exp. Ther. 275:1995;1367-1374.
40. Wise R.A., Rompre P.P. Brain dopamine and reward. Annu. Rev. Psychol. 40:1989;191-225.
41. Witkin J.M. Pharmacotherapy of cocaine abuse: preclinical development. Neurosci. Biobehav. Rev. 18:1994;121-142.
42. Witkin J.M., Nichols D.E., Terry P., Katz J.L. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J. Pharmacol. Exp. Ther. 257:1991;706-713.
43. Woolverton W.L., Goldberg L.I., Ginos J.Z. Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J. Pharmacol. Exp. Ther. 230:1984;678-683.